News & Updates

Artificial sweeteners may be making people overweight

11 Aug 2023 by

A study links long-term intake of artificial sweeteners to fat accumulation, increasing the risk of obesity regardless of diet quality or caloric intake.

Artificial sweeteners may be making people overweight

11 Aug 2023

Global NAFLD incidence on the rise

11 Aug 2023

Current estimates of nonalcoholic fatty liver disease (NAFLD) incidence across the world show an increasing trend, with 4,613 new cases per 100,000 person-years, reveals a study.

Global NAFLD incidence on the rise

11 Aug 2023

Serum NGAL predicts AKI, mortality in patients presenting to ED

11 Aug 2023 by

Use of serum neutrophil gelatinase-associated lipocalin (NGAL) can help identify acute kidney injury and predict 3-month mortality among patients presenting to the emergency department (ED) with “normal” creatinine, reports a Singapore study.

Serum NGAL predicts AKI, mortality in patients presenting to ED

11 Aug 2023

Smartphone provides exact renditions of adult muscle mass

11 Aug 2023 by

Smartphones now have the capacity to accurately render an adult’s level of muscularity through their image capture capabilities in combination with device software applications, a recent study has shown.

Smartphone provides exact renditions of adult muscle mass

11 Aug 2023

DQI-5 effectively evaluates diet quality of preschoolers in SG

11 Aug 2023 by

Using data from the GUSTO* cohort, the DQI-5 – a Diet Quality Index developed for preschool-aged children – effectively assessed the diet quality of 5-year-olds in Singapore.

DQI-5 effectively evaluates diet quality of preschoolers in SG

11 Aug 2023

Add-on cabozantinib confers survival benefit in advanced renal-cell carcinoma with caveat

11 Aug 2023

For patients with treatment-naïve advanced renal-cell carcinoma who have intermediate or poor prognostic risk, adding cabozantinib to the combination of nivolumab and ipilimumab significantly prolongs progression-free survival (PFS) compared with the combination alone but at the expense of increased grade 3 or 4 adverse events (AEs), as shown in a phase III trial.

Add-on cabozantinib confers survival benefit in advanced renal-cell carcinoma with caveat

11 Aug 2023

Gene therapy may help reverse hereditary vision loss

11 Aug 2023 by

Experimental gene therapy appears to improve eyesight in patients with a severe progressive form of Leber’s hereditary optic neuropathy (LHON) in an early access programme.

Gene therapy may help reverse hereditary vision loss

11 Aug 2023

TV habits in childhood may impact metabolic health in mid-adulthood

10 Aug 2023 by

Children and teens who watch a lot of television often grow to be adults with metabolic syndrome, obesity, or poor fitness, according to a study.

TV habits in childhood may impact metabolic health in mid-adulthood

10 Aug 2023

Selexipag a potential treatment for digital vasculopathy in SSc

10 Aug 2023

Use of selexipag shows promise in the treatment of systemic sclerosis (SSc) digital vasculopathy, according to a study.

Selexipag a potential treatment for digital vasculopathy in SSc

10 Aug 2023

Nutritional status predicts treatment tolerability, mortality risk in IPF patients

10 Aug 2023

The nutritional status of patients with idiopathic pulmonary fibrosis (IPF) has a significant impact on both treatment and outcome, suggests a study, noting that assessing the nutritional status offers helpful information for managing these individuals.

Nutritional status predicts treatment tolerability, mortality risk in IPF patients

10 Aug 2023

News & Updates

Filter by Specialty:

Specialty:

Artificial sweeteners may be making people overweight

Artificial sweeteners may be making people overweight

Global NAFLD incidence on the rise

Global NAFLD incidence on the rise

Serum NGAL predicts AKI, mortality in patients presenting to ED

Serum NGAL predicts AKI, mortality in patients presenting to ED

Smartphone provides exact renditions of adult muscle mass

Smartphone provides exact renditions of adult muscle mass

DQI-5 effectively evaluates diet quality of preschoolers in SG

DQI-5 effectively evaluates diet quality of preschoolers in SG

Add-on cabozantinib confers survival benefit in advanced renal-cell carcinoma with caveat

Add-on cabozantinib confers survival benefit in advanced renal-cell carcinoma with caveat

Gene therapy may help reverse hereditary vision loss

Gene therapy may help reverse hereditary vision loss

TV habits in childhood may impact metabolic health in mid-adulthood

TV habits in childhood may impact metabolic health in mid-adulthood

Selexipag a potential treatment for digital vasculopathy in SSc

Selexipag a potential treatment for digital vasculopathy in SSc

Nutritional status predicts treatment tolerability, mortality risk in IPF patients

Nutritional status predicts treatment tolerability, mortality risk in IPF patients